Pathophysiology and pathogenesis of diabetic foot syndrome [Pathophysiologie und pathogenese des diabetischen fußsyndroms]

被引:0
|
作者
Müller E. [1 ,2 ]
机构
[1] Schwerpunktpraxis für Nephrologie und Diabetologie, Kfh Nierenzentrum, Bernkastel-Kues
[2] Schwerpunktpraxis für Nephrologie und Diabetologie, Kfh Nierenzentrum Bernkastel-Kues, 54470 Bernkastel-Kues
来源
Der Diabetologe | 2006年 / 2卷 / 1期
关键词
Diabetic foot syndrome; Differential diagnostic considerations; Neuropathy; Pathophysiology; Risk factors;
D O I
10.1007/s11428-005-0020-8
中图分类号
学科分类号
摘要
As is known, the target set in the St. Vincent Declaration to reduce the rate of amputations by 50% in Europe was largely missed. It still holds true that "the majority of amputations could be prevented by correct differential diagnosis, appropriate differential therapy and suitable prophylaxis" (Ernst Chantelau). Most amputations are preceded by a foot lesion. These first develop due to an arrangement and the interaction of a series of risk components. These include besides the diabetes itself the diabetic sequelae and other factors. Their interaction leads to lesions and initiates processes that often result in an amputation with all its fateful and economic consequences. It is prerequisite for correct differential diagnosis and thus adequate differential therapy that risk factors are identified in detail and their individual role in a foot lesion assessed. Recognising the risks in a person with diabetes makes it ultimately possible to develop strategies for an individualised programme for prevention and to implement them. © Springer Medizin Verlag 2005.
引用
收藏
页码:9 / 17
页数:8
相关论文
共 50 条
  • [21] ZUR PATHOGENESE UND THERAPIE DES NEPHROTISCHEN SYNDROMS
    SARRE, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1954, 79 (46) : 1713 - 1717
  • [22] The ischemic form of diabetic foot syndrome. Potential for revascularisation [Die ischämische form des diabetischen fußsyndroms. Möglichkeiten der revaskularisation]
    Wölfle K.D.
    Bruijnen H.
    Loeprecht H.
    Gefässchirurgie, 2002, 7 (3) : 136 - 142
  • [23] PATHOGENESE UND THERAPIE DES ASCHER-SYNDROMS
    STEHR, K
    WERB, K
    LOBLICH, HJ
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1962, 87 (22) : 1148 - &
  • [24] Pathogenesis of diabetic podopathy [Zur pathogenese der diabetischen podopathie]
    Chantelau E.
    Der Internist, 1999, 40 (10): : 994 - 1001
  • [25] ZUR PATHOGENESE UND THERAPIE DES NEPHROTISCHEN SYNDROMS
    SARRE, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1954, 79 (45) : 1652 - 1654
  • [26] Revaskularisation beim diabetischen Fußsyndrom? Wann und wie?Revascularization in diabetic foot syndrome? When and how?
    Ulrich Rother
    Hartmut Görtz
    Christian Uhl
    Konstantinos Stavroulakis
    Elena Marchiori
    Simon Classen
    Achim Neufang
    Axel Larena-Avellaneda
    Dmitriy Dovzhanskiy
    Christian-Alexander Behrendt
    Gefässchirurgie, 2024, 29 (2) : 81 - 86
  • [27] New insights into the pathogenesis and pathophysiology of depression [Neue erkenntnisse zur pathogenese und pathophysiologie der depression]
    Schüle C.
    Baghai T.C.
    Rupprecht R.
    Der Nervenarzt, 2007, 78 (Suppl 3) : 531 - 550
  • [28] Etiology and pathophysiology of fibromyalgia syndrome [Ätiologie und Pathophysiologie des Fibromyalgiesyndroms]
    Sommer C.
    Häuser W.
    Burgmer M.
    Engelhardt R.
    Gerhold K.
    Petzke F.
    Schmidt-Wilcke T.
    Späth M.
    Tölle T.
    Üçeyler N.
    Wang H.
    Winkelmann A.
    Thieme K.
    Der Schmerz, 2012, 26 (3) : 259 - 267
  • [29] Aktueller Stand bezuglich des diabetischen Fußsyndroms in Deutschland: Grundsatzliches und Strategien fur Diagnose, Therapie und Prophylaxe
    Morbach, Stephan
    Hochlenert, Dirk
    Eckhard, Michael
    DIABETOLOGIE, 2024, 20 (01): : 1 - 10
  • [30] Update zum diabetischen FußsyndromUpdate on the diabetic foot
    T. Tanudjaja
    M. Spraul
    Der Diabetologe, 2015, 11 (4): : 309 - 319